Citation Tools

Download PDFPDF

330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies

Download to a citation manager

Cite this article as:
Herting C, Zhang Y, Doxie D, et al
330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies